Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 212

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Silent Nucleotide Polymorphisms and a Phylogeny for Mycobacterium tuberculosis

Open access
Baker, Lucy, Brown, Tim, Maiden, Martin C., Drobniewski, Francis·2004·Emerging Infectious Diseases

Abstract

Much remains unknown of the phylogeny and evolution of Mycobacterium tuberculosis, an organism that kills 2 million people annually.Using a population-based approach that analyzes multiple loci around the chromosome, we demonstrate that neutral genetic variation in genes associated with antimicrobial drug resistance has sufficient variation to construct a robust phylogenetic tree for M. tuberculosis.The data describe a clonal population with a minimum of four distinct M. tuberculosis lineages, closely related to M. bovis.The lineages are strongly geographically associated.Nucleotide substitutions proven to cause drug resistance are distributed throughout the tree, whereas nonsynonymous base substitutions unrelated to drug resistance have a restricted distribution.The phylogenetic structure is concordant with all the previously described genotypic and phenotypic groupings of M. tuberculosis strains and provides a unifying framework for both epidemiologic and evolutionary analysis of M. tuberculosis populations.M ycobacterium tuberculosis has caused tuberculosis (TB) in humans for thousands of years (1,2), and the World Health Organization (WHO) estimates that one third of the global population is infected with M. tuberculosis (3); however, the bacterium has remained an enigma.The global resurgence of TB highlights the need for an improved understanding of its epidemiology and its evolutionary biologic features.Recent advances in molecular characterization of M. tuberculosis isolates, which index variation in insertion sequences (4) and repetitive genomic elements (5,6), have elucidated clusters of identical and closely related strain families (7-9).These findings have provided insights into regional (10) and national (11) epidemiologic features.However, these techniques may be less suited to global population and evolutionary analyses, and integrating information obtained from different approaches is complex (12).Genomic comparisons have identified genetic variation for population screening; however, these analyses are limited to those sites that vary between the compared genomes and are potentially misleading (13-15).Nucleotide sequences provide robust, portable, and comparable data for studying population variation.The mutational processes that generate this variation are understood, and sequence data have been successfully used in the study of bacterial epidemiology, population biology, and evolution ( 16).The complete genome sequences (15-18) provide access to all regions of the chromosome and facilitate such studies.However, high-throughput gene sequencing of structural genes (19) and host immune system protein targets (20) in M. tuberculosis isolates indicated low levels of sequence diversity.Although extensive genomic sequencing was performed in both studies, comparable sequence data were obtained on a limited number of highly selected isolates.We used an unbiased population approach to analyze genetically silent nucleotide sequence variation for seven unlinked loci distributed around the chromosome.The loci chosen were genes associated with antimicrobial drug resistance that have been reported to possess >95% of all sequence variation observed in 26 structural genes studied (19), which includes >90% of synonymous nucleotide substitutions, i.e., nucleotide substitutions that do not affect the translated amino acid.In a population sample of 316 U.K. clinical isolates, silent single nucleotide polymorphisms (sSNPs) resolve an unambiguous phylogeny and provide a unifying framework for epidemiologic, population, and evolutionary analyses. Methods Bacterial StrainsThe 316 M. tuberculosis clinical isolates were identified in England and Wales from January 1, 1998, through

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3201/eid1009.040046

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 212

Metadata

Authors
Baker, L., Brown, T., Maiden, M. C., & Drobniewski, F.
Venue
Emerging Infectious Diseases
Published
2004-09
Volume
10
Issue
9
Pages
1568-1577
ISSN
  • 1080-6040 (ISSN-L)
  • 1080-6059
OpenAlex
W1969464199
Cited by
212
References
4
FWCI
7.84
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Silent Nucleotide Polymorphisms and a Phylogeny for Mycobacterium tuberculosis. https://app.cochat.ai/papers/10.3201/eid1009.040046
The paper
Baker, L., Brown, T., Maiden, M. C., & Drobniewski, F. (2004). Silent Nucleotide Polymorphisms and a Phylogeny for Mycobacterium tuberculosis. Emerging Infectious Diseases. https://doi.org/10.3201/eid1009.040046

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.